CompletedNCT00050804
Evaluation of Stress Disorders
Medication studyUnited StatesPTSD
Understand this study
We have not yet verified a detailed participation summary for this study.
- Listed locations
- Bethesda, United StatesSee all locations and recruitment
- Activities
- Medication described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateDecember 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 80
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT00050804
- Official title
Show the full official title
Efficacy of an SSRI in Acute Stress Disorder and PTSD
Recruitment & locations
CompletedBethesda
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including sertraline.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01861847
7-Keto DHEA for PTSD
United States
CompletedNCT03508700
TNX-102 SL 5.6 mg Taken Daily at Bedtime for PTSD
United States
CompletedNCT00554177
A study for PTSD
United States